These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24619092)

  • 21. Positive allosteric modulation of A
    Vincenzi F; Ravani A; Pasquini S; Merighi S; Gessi S; Romagnoli R; Baraldi PG; Borea PA; Varani K
    Neuropharmacology; 2016 Dec; 111():283-292. PubMed ID: 27639989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The allosteric enhancer, PD 81,723, stabilizes human A1 adenosine receptor coupling to G proteins.
    Bhattacharya S; Linden J
    Biochim Biophys Acta; 1995 Feb; 1265(1):15-21. PubMed ID: 7857979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclopentyladenosine-induced homologous down-regulation of A1 adenosine receptors (A1AR) in intact neurons is accompanied by receptor sequestration but not a reduction in A1AR mRNA expression or G protein alpha-subunit content.
    Hettinger BD; Leid M; Murray TF
    J Neurochem; 1998 Jul; 71(1):221-30. PubMed ID: 9648869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probe dependence of allosteric enhancers on the binding affinity of adenosine A
    Cooper SL; Soave M; Jörg M; Scammells PJ; Woolard J; Hill SJ
    Br J Pharmacol; 2019 Apr; 176(7):864-878. PubMed ID: 30644086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and in Vivo Characterization of A
    Tosh DK; Rao H; Bitant A; Salmaso V; Mannes P; Lieberman DI; Vaughan KL; Mattison JA; Rothwell AC; Auchampach JA; Ciancetta A; Liu N; Cui Z; Gao ZG; Reitman ML; Gavrilova O; Jacobson KA
    J Med Chem; 2019 Feb; 62(3):1502-1522. PubMed ID: 30605331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agonist-independent effect of an allosteric enhancer of the A1 adenosine receptor in CHO cells stably expressing the recombinant human A1 receptor.
    Kollias-Baker CA; Ruble J; Jacobson M; Harrison JK; Ozeck M; Shryock JC; Belardinelli L
    J Pharmacol Exp Ther; 1997 May; 281(2):761-8. PubMed ID: 9152383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism.
    Vecchio EA; Baltos JA; Nguyen ATN; Christopoulos A; White PJ; May LT
    Br J Pharmacol; 2018 Nov; 175(21):4036-4046. PubMed ID: 29679502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.
    Ferguson GN; Valant C; Horne J; Figler H; Flynn BL; Linden J; Chalmers DK; Sexton PM; Christopoulos A; Scammells PJ
    J Med Chem; 2008 Oct; 51(19):6165-72. PubMed ID: 18771255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
    Feng Z; Hu G; Ma S; Xie XQ
    AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel selective allosteric and bitopic ligands for the S1P(3) receptor.
    Jo E; Bhhatarai B; Repetto E; Guerrero M; Riley S; Brown SJ; Kohno Y; Roberts E; Schürer SC; Rosen H
    ACS Chem Biol; 2012 Dec; 7(12):1975-83. PubMed ID: 22971058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Irreversible Agonists Acting at the A
    Jörg M; Glukhova A; Abdul-Ridha A; Vecchio EA; Nguyen AT; Sexton PM; White PJ; May LT; Christopoulos A; Scammells PJ
    J Med Chem; 2016 Dec; 59(24):11182-11194. PubMed ID: 27958734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).
    Jacobson KA
    Bioconjug Chem; 2009 Oct; 20(10):1816-35. PubMed ID: 19405524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.
    Valant C; Gregory KJ; Hall NE; Scammells PJ; Lew MJ; Sexton PM; Christopoulos A
    J Biol Chem; 2008 Oct; 283(43):29312-21. PubMed ID: 18723515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
    Rivkees SA; Lasbury ME; Barbhaiya H
    J Biol Chem; 1995 Sep; 270(35):20485-90. PubMed ID: 7657625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding mode.
    Digby GJ; Utley TJ; Lamsal A; Sevel C; Sheffler DJ; Lebois EP; Bridges TM; Wood MR; Niswender CM; Lindsley CW; Conn PJ
    ACS Chem Neurosci; 2012 Dec; 3(12):1025-36. PubMed ID: 23259038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological Insights Into Safety and Efficacy Determinants for the Development of Adenosine Receptor Biased Agonists in the Treatment of Heart Failure.
    Rueda P; Merlin J; Chimenti S; Feletou M; Paysant J; White PJ; Christopoulos A; Sexton PM; Summers RJ; Charman WN; May LT; Langmead CJ
    Front Pharmacol; 2021; 12():628060. PubMed ID: 33776771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allosteric Antagonism of the A
    Gao ZG; Toti KS; Campbell R; Suresh RR; Yang H; Jacobson KA
    Cells; 2020 May; 9(5):. PubMed ID: 32408534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.
    Romagnoli R; Baraldi PG; Carrion MD; Cruz-Lopez O; Cara CL; Saponaro G; Preti D; Tabrizi MA; Baraldi S; Moorman AR; Vincenzi F; Borea PA; Varani K
    Bioorg Med Chem; 2014 Jan; 22(1):148-66. PubMed ID: 24332652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity.
    Stewart GD; Valant C; Dowell SJ; Mijaljica D; Devenish RJ; Scammells PJ; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2009 Oct; 331(1):277-86. PubMed ID: 19641164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.